Soleno Therapeutics(SLNO.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Soleno Therapeutics
SLNO.US
Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc.
1.813 T
SLNO.USMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
B
BiotechnologyIndustry
Industry Ranking32/387
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE26.27%A
    • Profit Margin33.70%A
    • Gross Margin98.73%A
  • Growth ScoreB
    • Revenue YoY0.00%D
    • Net Profit YoY148.24%A
    • Total Assets YoY91.26%A
    • Net Assets YoY113.47%A
  • Cash ScoreC
    • Cash Flow Margin110.36%C
    • OCF YoY0.00%D
  • Operating ScoreB
    • Turnover0.62B
  • Debt ScoreA
    • Gearing Ratio18.51%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Neurocrine Unveils New INGREZZA Findings In Mild Tardive Dyskinesia At APA 2026; Closes Soleno Deal

    nasdaq·
    US
    NBIX
    -0.76%
    US
    SLNO
    0.00%
    US
    IXJ
    +0.51%
    nasdaq·
    US
    NBIX
    -0.76%
    US
    SLNO
    0.00%
    US
    IXJ
    +0.51%

    Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics | NBIX Stock News

    StockTitan·
    US
    NBIX
    -0.76%
    US
    FBT
    -0.66%
    US
    ARKG
    -0.14%
    StockTitan·
    US
    NBIX
    -0.76%
    US
    FBT
    -0.66%
    US
    ARKG
    -0.14%

    13:32 ETSLNO 8-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphagia Drug Launch Disruptions - Hagens Berman

    prnewswire·
    US
    SLNO
    0.00%
    US
    LABD
    +6.62%
    US
    BBH
    -1.03%
    prnewswire·
    US
    SLNO
    0.00%
    US
    LABD
    +6.62%
    US
    BBH
    -1.03%

    17:57 ETAre SEM, XOMA, SLNO, KORE Obtaining Fair Deals for their Shareholders?

    prnewswire·
    US
    SLNO
    0.00%
    US
    KORE
    -0.11%
    US
    SEM
    -0.12%
    prnewswire·
    US
    SLNO
    0.00%
    US
    KORE
    -0.11%
    US
    SEM
    -0.12%

    Neurocrine Biosciences Q1 Adjusted Earnings, Revenue Rise

    fidelity·
    US
    NBIX
    -0.76%
    fidelity·
    US
    NBIX
    -0.76%
    © 2026 Longbridge｜Disclaimer